Entreprise · 14/11/20261 min de lecture
CARsgen's CAR-T Product Satri-cel Included in China's Commercial Health Insurance Innovative Drug List
Traduction automatique locale · Langue originale de la source
Résumé
SHANGHAI, Nov. 14, 2026 — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that satricabtagene autoleucel…